MVision AI
News and Articles

Keep up to date with our latest articles

Hot Topics 🔥

Press Room

13.11.2023

The future of AI in Radiotherapy, and how does MVision AI plan to further enhance its offerings in this field

The interview of Jarkko Niemelä, CEO, and Co-founder of MVision AI, for IntelligentHealth.tech magazine. October 2023. What specific challenges does Contour+ address in the field of radiotherapy, and how does its AI-powered automation contribute to overcoming these challenges? The largest challenge in cancer radiotherapy is the shortage of experts, including…

Articles

10.11.2023

Man vs. Machine (Learning): Comparing Speed and Cost-Effectiveness of Manual vs. Deep Learning Segmentation-Aided Volume Delineation for Head and Neck Lymph Node Targets

This preliminary study shows that using an AI-based segmentation-aided approach to Head and Neck Lymph Node stations can be feasibly implemented within a standard Radiation Oncology workflow!MVision AI's guideline-based Contour+ offers the potential for significant time and cost savings in your Radiation Therapy department.

Articles

27.10.2023

MVision AI is proud to announce the installation of its Contour+ at Nemocnica Bory Hospital in Slovakia

HELSINKI, Finland - October 27, 2023 MVision AI has been chosen as the preferred provider of an auto-contouring solution (Contour+) for the radiation therapy department, under the leadership of MUDr. Margita Pobijáková, PhD. Additionally, the company is an integral part of the Oncology program, alongside Elekta Linac and the first…

Press Releases

23.10.2023

MVision AI Contour+ (Guideline-Based AI Segmentation): highlights from an independent validation study using a comprehensive and curated data set

Overall, 87% of the radiation oncologists who participated in the study gave the MVision AI Contour+ a score of 4 or 5 (minor or no editing required). How to properly test an AI-based auto-contouring solution? Artificial-intelligence applications are becoming increasingly popular in medicine, including Radiotherapy. Before AI-based tools can be…

Articles

19.10.2023

Breast cancer radiotherapy – Exciting news about concomitant boost for hypofractionated treatment schedules

One of the important studies presented at the recent ASTRO 2023 meeting provided strong evidence for  the safety and efficacy of concomitant boost during hypofractionated radiotherapy for breast cancer. Currently, about 60% of women with breast cancer receive conservative surgery, followed by radiotherapy (1). Previous studies showed that for conservative…

Articles

10.10.2023

The clinician of the future – empowered by AI

Elsevier Health recently published a “Clinician of the future” report, based on the results of an online survey which gathered the perspectives of more than 2600 clinicians from 116 countries. They expressed their opinions on the future of healthcare, the opportunities and challenges they are facing in their roles. Perspectives…

Articles

29.9.2023

MVision AI is proud to announce the launch of the world’s first comprehensive Guideline-Based Segmentation (GBS™) solution for responsible radiation therapy contouring

HELSINKI, Finland - September 29, 2023 The launch of MVision AI’s GBS™ solution is timed to coincide with the release of two new products - Guide and Verify. Guide empowers clinical teams to competently review AI-generated structures, thereby helping them to refine their contouring skills. Our solution offers a library…

Press Releases

14.9.2023

Press Release: MVision AI is selected to provide its Contour+ solution by the Republic of Ireland’s Health Service Executive (HSE) for its first installation in the country

HELSINKI, Finland - September 14, 2023 MVision AI is experiencing ongoing and rapid growth within the health service sector globally. The company is delighted to announce that we have successfully been awarded the tender from the Republic of Ireland’s Health Service Executive (HSE) for the installation of our Contour+ auto…

Press Releases

28.8.2023

📍Research Results of MVision AI Contour+ Models’ Clinical Evaluation

Key facts: Professionals working in 40 clinics from 31 countries assessed MVision AI's Contour+ solution (Figure 1). More than 11 800 structures were evaluated on 1353 scans (Figure 2). Detailed results can be found in 5 full text articles published in 3 Peer-reviewed journals (Diagnostics 2020, Physics and Imaging in…

Articles

25.8.2023

🎉 Exciting News: AI Auto-Contouring Recommended by NICE for Radiotherapy in the NHS! 🎉

We are thrilled to share a significant milestone that showcases the remarkable impact of innovation in radiotherapy. A number of AI auto-contouring tools, including MVision AI's Contour+, have been officially recommended by NICE (National Institute for Health and Care Excellence) for use within the NHS. This endorsement is a testament…

News

24.8.2023

Press Release: MVision AI launches Contour+ auto-contouring to facilitate standardization and shorten time to treatment for cancer radiotherapy

HELSINKI, Finland - August 24, 2023MVision AI is proud to announce the new software release version 1.2.4 of its guideline-based automatic segmentation service. Along with new contouring models and advanced Region-Of-Interest (ROI) operations, MVision AI’s outstanding contouring product is being rebranded. The introduction of Contour+ extends clinical applications and elevates…

Press Releases

8.8.2023

Clinical User Experience with MVision AI

This is a webinar that you don’t want to miss! You’ll hear from an actual user and their clinical experience with MVision’s AI-powered software. Please join us as our guest speaker, Ryan Schurr from UMC in Lubbock, Texas, presents his experience with MVision AI and how MVision enhanced UMC’s…

Webinars and Videos

Testimonials

Hear what people say about us.

Customer Portfolio